$49.80 B
๐Ÿ‡บ๐Ÿ‡ธ USA
Share price
Change (1 day)
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Market capitalization of Biogen (BIIB)

Market cap: $49.80 Billion

As of July 2021 Biogen has a market cap of $49.80 Billion. This makes Biogen the world's 380th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Biogen from 2004 to 2021

Year Market cap Change
2021$48.91 B29.82%
2020$37.67 B-27.11%
2019$51.69 B-12.89%
2018$59.34 B-11.92%
2017$67.37 B9.19%
2016$61.69 B-7.87%
2015$66.96 B-15.89%
2014$79.62 B20.51%
2013$66.07 B90.8%
2012$34.62 B29.53%
2011$26.73 B65.75%
2010$16.12 B9.68%
2009$14.70 B7.18%
2008$13.71 B-18.49%
2007$16.83 B1.49%
2006$16.58 B7.9%
2005$15.36 B-32.09%
2004$22.63 B